About the Journal

The Journal of Orthopaedic Business aims to improve the lives of patients and physicians by increasing the efficiency of orthopaedic surgery.

The journal publishes Level IV or stronger evidence that illuminates best practices in clinic management, operative techniques, staffing, and finance.

The Journal of Orthopaedic Business is committed to open access to facilitate the spread of best practices.

ISSN 2771-3040

Member of Crossref

DOI prefix: 10.55576

Peer Review Process and Editorial Decisions

Scientific articles and all other manuscripts submitted to JOB are first reviewed by our chief editors and/or deputy editors. JOB relies on its editorial staff to determine article appropriateness, timeliness, and relevancy to orthopaedic surgery. In specific circumstances, a manuscript may subsequently be routed to an associate editor for particular expertise or to optimize editorial workflow. Some manuscripts are rejected after such initial reviews. In most cases, articles are sent to two or more reviewers for double-anonymized peer review. At no time are the identities of authors or reviewers disclosed to one another. After initial review, the corresponding chief editor and/or deputy editor will reject, return for revisions, or accept the manuscript based on the reviewers' responses.

JOB strives to follow the COPE Code of Conduct and Best Practice Guidelines for Journal Editors.

Authors reserve the right to appeal an editorial rejection by sending an email to the editorial office. The choice to uphold the initial decision, offer a chance at revision, or discuss the paper further amongst deputy editorial staff is at the discretion of the Editor-in-Chief.

Conflict of Interest

The Editor-in-Chief certifies no commercial associations (consultancies, stock ownership, equity interest, patent/licensing arrangements, etc.) that might pose a conflict of interest in connection with the peer review process and final determination of each article.

All JOB deputy editors have disclosed any conflicts of interest to the Editor-in-Chief. Relevant conflicts are taken into consideration and may result in recusal from the editorial review process of involved article(s). In such circumstances, either another deputy editor or associate editor with relevant expertise is chosen to be an acting/handling editor of the involved article(s).

Reviewers, associate editors, and/or invited parties during the review process may have a conflict of interest or a competing interest regarding the subject matter of a manuscript. Such conflicts are to be disclosed to the Editor-in-Chief and/or handling editor as early in the review process as possible. If warranted, the article(s) will be reassigned to another invited individual who has demonstrated expertise in the subject matter.

Authors are required to reveal any conflicts of interest when they submit the manuscript. The information contained in the disclosure statement has no bearing on the editorial decision to publish a manuscript. A summary of the statements selected by the author(s) will be published with the article. Similarly, all funding sources must be disclosed in the manuscript text at the time of submission and will be published with the article.

Open Access and Fees

The Journal of Orthopaedic Business is fully open access. Every article is freely available to read, download, and distribute from the moment it is published.

The journal charges no fees of any kind at any stage. There are no submission fees, no article processing charges, no page charges, and no charges for color figures. Publication is free to authors and free to readers.

Copyright and Licensing

Authors retain copyright of their work. Upon acceptance, authors grant the Journal of Orthopaedic Business a license to publish. All articles are published under a Creative Commons Attribution 4.0 International (CC BY 4.0) license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and the journal are properly credited.

Exceptions for specific illustrations or videos require appropriate documentation and must be requested at the time of submission, subject to written mutual agreement.

If published material is found to be fraudulent or to contain falsified data, or if other evidence is found to indicate that the material violates ethical standards, JOB follows the COPE guidelines to determine the appropriate action.

Data Sharing

The journal encourages authors to share the data and other artifacts supporting the results in the paper by archiving them in an appropriate public repository. Authors may provide a data availability statement, including a link to the repository they have used, so that this statement can be published in their paper. Shared data should be cited. All accepted manuscripts may elect to publish a data availability statement to confirm the presence or absence of shared data.

Advertising

The Journal of Orthopaedic Business does not currently carry advertising. Should the journal accept advertising in the future, the following policy applies.

Advertising is independent of editorial content and has no influence on editorial decisions. The journal does not endorse any advertised product or service, and advertisers have no influence over search results or over which articles appear alongside their advertising. Advertisements are clearly distinguishable from editorial content. The journal does not publish advertorial content, and any sponsored supplement is identified as such, together with a statement of whether it underwent peer review.

Advertisements may not be targeted to specific articles, keywords, or search terms, and may not be placed adjacent to content relating to the advertised product. The journal does not accept advertising for tobacco or alcohol products, or for any product or service known to be harmful to health. Advertisements must be accurate, verifiable, and not misleading; must identify the advertiser and the product or service offered; and must not contain content that is indecent, offensive, or discriminatory. Advertising for prescription-only medicines must comply with applicable United States regulations and must be clearly labeled as intended for health professionals.

The Editor-in-Chief may decline any advertisement, or withdraw a published advertisement at any time, at their sole discretion. Complaints concerning advertising should be sent to BenRChilds@JOrthoBusiness.org.

Corrections

To request a correction, please email BenRChilds@JOrthoBusiness.org and we will respond as soon as possible.